Hu jian starry pharma
WebZhejiang Starry Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of active ingredient and intermediate X-CT non-ionic contrast agent and fluoroquinolones... WebGet Zhejiang Starry Pharmaceutical company profile, including company overview, stock issuing data, contact information, and corperate business. ... Zhejiang Sili Pharmaceutical Co., Ltd. was founded in 1997, is a professional research and development, production and sales of X-CT Nonionic contrast agent series and quinolone series of raw ...
Hu jian starry pharma
Did you know?
WebSee the company profile for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) including business summary, industry/sector information, number of employees, business summary, corporate governance ... WebSep 21, 2024 · Zhejiang Starry Pharmaceutical Co., Ltd. added to S&P Global BMI Index... August 15, 2024
WebZhejiang Starry Pharmaceutical Co., Ltd. is a high-tech enterprise specialized in research and development, production and sales of X-CT nonionic iodine contrast agent series … WebCompany profile for Zhejiang Starry Pharmaceutical Co. Ltd. A including key executives, insider trading, ownership, revenue and average growth rates. View detailed 603520.CN description & address.
WebSee the company profile for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives and their compensation. WebZhejiang Starry Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of active ingredient and intermediate X-CT non-ionic contrast agent and fluoroquinolones series.
Web58,7%. More Financials. Company. Zhejiang Starry Pharmaceutical Co., Ltd. is principally engaged in the research and development (R&D), production and sales of X-ray contrast …
WebZhejiang Ruian Hualian Pharmaceutical Machinery Technology Co., Ltd. specializes in the research and development, production and related technical services of automated … showcase familyWebCEO Jian Hu (43 yo) 2.83yrs Tenure CN¥1,183,200 Compensation Mr. Hu Jian is GM, Acting Secretary of the Board of Directors & Director at Zhejiang Starry Pharmaceutical … showcase fang frame card style rewardsWebAs on March 28, 2024, The transaction has been considered and approved by directors of the Zhejiang Starry Pharmaceutical Co.,Ltd. Within 7 trading days from the date of signing the contract, the entire transaction price of 35 million yuan will be paid to the company's designated account at one time. showcase fanhttp://en.starrypharm.com/news/5/ showcase family ticket ageshttp://en.starrypharm.com/ showcase farmingdaleWebZHEJIANG STARRY employes about 1.5 K people. The company is managed by 17 executives with total tenure of roughly 27 years, averaging almost 1.0 years of service per executive having 87.47 employees per reported executive. Analysis of ZHEJIANG STARRY management performance can provide insight into the company performance. showcase farmingdale multiplexWebShould you invest in Zhejiang Starry PharmaceuticalLtd (XSSC:603520)? High growth potential with questionable track record. Home Markets Discover Watchlist Portfolios Screener. Stocks / China / Pharmaceuticals & Biotech; Zhejiang Starry PharmaceuticalLtd XSSC:603520 Stock Report. Last Price. CN¥18.88. Market Cap. CN¥6.5b. 7D-0.6%. 1Y … showcase family ticket uk